Hims & Hers Health Inc’s filing revealed that its Chief Legal Officer Boughton Soleil unloaded Company’s shares for reported $34917.0 on Apr 15 ’24. In the deal valued at $13.95 per share,2,503 shares were sold. As a result of this transaction, Boughton Soleil now holds 164,363 shares worth roughly $1.95 million.
Then, Baird Melissa sold 11,751 shares, generating $173,254 in total proceeds. Upon selling the shares at $14.74, the Chief Operating Officer now owns 538,932 shares.
Before that, Baird Melissa sold 11,751 shares. Hims & Hers Health Inc shares valued at $171,372 were divested by the Chief Operating Officer at a price of $14.58 per share. As a result of the transaction, Baird Melissa now holds 538,932 shares, worth roughly $6.4 million.
Jefferies downgraded its Hims & Hers Health Inc [HIMS] rating to a Hold from a a Buy in a research note published on April 16, 2024; the price target was decreased to $15 from $17. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Imperial Capital also remained covering HIMS and has increased its forecast on February 28, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. Leerink Partners started covering the stock on February 26, 2024. It rated HIMS as “a Market perform”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock fall -0.17% to $11.88. Over the last five days, the stock has lost -10.14%. Hims & Hers Health Inc shares have risen nearly 33.48% since the year began. Nevertheless, the stocks have risen 9.39% over the past one year. While a 52-week high of $17.16 was reached on 03/25/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $13.44, while 200 days put it at $9.09. A total of 3.45 million shares were traded, compared to the trading of 3.55 million shares in the previous session.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 11.63, which if violated will result in even more drops to 11.38. On the upside, there is a resistance level at 12.09. A further resistance level may holdings at 12.30. The Relative Strength Index (RSI) on the 14-day chart is 30.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.65, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.06%. Stochastics %K at 4.91% indicates the stock is a buying.
The most recent change occurred on December 07, 2023 when Imperial Capital began covering the stock and recommended ‘”an In-line”‘ rating along with a $9 price target.
